3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Pancreatic Neoplasms
108
Breast Neoplasms
72
Carcinoma, Non-Small-Cell Lung
38
Triple Negative Breast Neoplasms
29
Squamous Cell Carcinoma of Head and Neck
18
Neoplasm Metastasis
14
Esophageal Squamous Cell Carcinoma
14
Neoplasms
12
Head and Neck Neoplasms
11
Lung Neoplasms
10
Stomach Neoplasms
9
Gallbladder Neoplasms
8
Cholangiocarcinoma
8
Adenocarcinoma
8
Melanoma
7
Esophageal Neoplasms
7
Biliary Tract Neoplasms
7
Sarcoma
6
Ovarian Neoplasms
5
Inflammatory Breast Neoplasms
5
Small Cell Lung Carcinoma
4
Recurrence
4
Pancreatic Adenocarcinoma
4
Carcinoma, Ductal, Breast
4
Uveal Melanoma
3
Uterine Cervical Neoplasms
3
Tongue Neoplasms
3
Thymoma
3
Pancreatic Diseases
3
Nasopharyngeal Carcinoma
3
Interventions
Nivolumab
3
Cisplatin
2
Albumin-Bound Paclitaxel
2
tislelizumab
1
spartalizumab
1
Taxes
1
Standard of Care
1
Radiotherapy
1
Neoadjuvant Therapy
1
Immunotherapy
1
Gemcitabine
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Muscle-Invasive Bladder Carcinoma
×
130-nm albumin-bound paclitaxel
×
Clear all
NCT04876313
2022-04-06
NURE-Combo
IRCCS San Raffaele
Phase 2
Unknown
29 enrolled